Cargando…

Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats

Portal hypertension develops along with liver cirrhosis then induces the formation of portal-systemic collaterals and lethal complications. Extrahepatic angiogenesis plays an important role. Glycyrrhizin has been found to exhibit anti-angiogenic features, which leads to its extensive use. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pun, Chon Kit, Huang, Hui-Chun, Chang, Ching-Chih, Chuang, Chiao-Lin, Yen, Chun-Hsien, Hsu, Shao-Jung, Lee, Fa-Yauh, Hou, Ming-Chih, Huang, Yi-Hsiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304322/ https://www.ncbi.nlm.nih.gov/pubmed/34299285 http://dx.doi.org/10.3390/ijms22147662

Ejemplares similares

Matrix metalloproteinase‐9 inhibition or deletion attenuates portal hypertension in rodents
por: Huang, Hui‐Chun, et al.
Publicado: (2021)

Diabetes Diminishes the Portal-Systemic Collateral Vascular Response to Vasopressin via Vasopressin Receptor and G(α) Proteins Regulations in Cirrhotic Rats
por: Lee, Jing-Yi, et al.
Publicado: (2013)

Effects of PCSK-9 Inhibition by Alirocumab Treatments on Biliary Cirrhotic Rats
por: Huang, Hui-Chun, et al.
Publicado: (2022)

The beneficial effects of curcumin in cirrhotic rats with portal hypertension
por: Hsu, Shao-Jung, et al.
Publicado: (2017)

Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats
por: Hsu, Shao-Jung, et al.
Publicado: (2020)

The collateral caval shunt as an alternative to classical shunt procedures in patients with recurrent duodenal varices and extrahepatic portal vein thrombosis
por: Hau, Hans Michael, et al.
Publicado: (2014)

Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats
por: Chang, Ching-Chih, et al.
Publicado: (2017)

Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats
por: Chang, Ching-Chih, et al.
Publicado: (2019)

Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction
por: Artru, Florent, et al.
Publicado: (2022)

Unconventional shunt surgery for non-cirrhotic portal hypertension in patients not suitable for proximal splenorenal shunt
por: S L, Harilal, et al.
Publicado: (2023)

Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction
por: Zhou, Yongjie, et al.
Publicado: (2023)

Application of transmesenteric vein extrahepatic portosystemic shunt in treatment of symptomatic portal hypertension with cavernous transformation of portal vein
por: Li, Weixiao, et al.
Publicado: (2023)

The Diminished Expression of Proangiogenic Growth Factors and Their Receptors in Gastric Ulcers of Cirrhotic Patients
por: Luo, Jiing-Chyuan, et al.
Publicado: (2013)

Surgical management of extrahepatic portal vein obstruction in children: advantages of MesoRex shunt compared with distal splenorenal shunt
por: Khamag, Omar, et al.
Publicado: (2023)

Surgical Ligation of Extrahepatic Shunt under Guidance of Doppler Ultrasound, Portography, and Portal Pressure Monitoring
por: Shimoda, Mitsugi, et al.
Publicado: (2012)

Use of meso-Rex shunt with transposition of the coronary vein for the management of extrahepatic portal vein obstruction
por: Cho, Yong-Pil, et al.
Publicado: (2014)

Prevalence and pattern of growth abnormalities in children with extrahepatic portal vein obstruction: Response to shunt surgery
por: Mir, Toufeeq Ahmad, et al.
Publicado: (2016)

Congenital extrahepatic portosystemic shunt masquerading as chronic portal vein thrombosis: A case report
por: Tamiru, Raja, et al.
Publicado: (2023)

Proximal Splenorenal Shunt Surgery for Bleeding Gastric Varices in Non-Cirrhotic Portal Hypertension
por: Anand, Utpal, et al.
Publicado: (2020)

NAFLD Aggravates Septic Shock Due to Inadequate Adrenal Response and 11β-HSDs Dysregulation in Rats
por: Huang, Hui-Chun, et al.
Publicado: (2020)

Splenectomy with endotherapy in non-cirrhotic portal fibrosis related portal hypertension: Can it be an alternative to proximal spleno-renal shunt?
por: Saluja, Sundeep Singh, et al.
Publicado: (2020)

Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension
por: Yan, Xuan-Hui, et al.
Publicado: (2022)

Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats
por: Gao, Jin-Hang, et al.
Publicado: (2016)

Modified Meso-Rex Shunt for Extrahepatic Portal Vein Obstruction and Variceal Bleeding after Pancreatoduodenectomy in an Adult
por: Cho, Ara, et al.
Publicado: (2022)

Status of congenital extrahepatic portosystemic shunt
por: Zeng, Pan, et al.
Publicado: (2022)

Extrahepatic Portal Vein Aneurysm
por: Gaba, Ron C., et al.
Publicado: (2016)

Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation
por: Hung, Hao-Chien, et al.
Publicado: (2020)

Portal Fibrotic Cord is Associated with Transjugular Intrahepatic Portosystemic Shunt Failure and Death in Cirrhotic Patients
por: Yang, Yunshu, et al.
Publicado: (2023)

Carvedilol Ameliorates Intrahepatic Angiogenesis, Sinusoidal Remodeling and Portal Pressure in Cirrhotic Rats
por: Ling, Liping, et al.
Publicado: (2018)

Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats
por: Chang, Ting, et al.
Publicado: (2019)

Correction: Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats
por: Gao, Jin-Hang, et al.
Publicado: (2022)

Transjugular intrahepatic collateral-systemic shunt is effective for cavernous transformation of the portal vein with variceal bleeding
por: Tie, Jun, et al.
Publicado: (2023)

Effect of Shunting of Collateral Flow into the Venous System on Arteriogenesis and Angiogenesis in Rabbit Hind Limb
por: Yang, Bao-lin, et al.
Publicado: (2013)

Hepatic encephalopathy due to extrahepatic portosystemic shunt
por: Sazumi, Yosuke, et al.
Publicado: (2020)

Innovative angiography: a new approach to discover more hepatic vein collaterals in patients with cirrhotic portal hypertension
por: Liu, Bowen, et al.
Publicado: (2023)

Cirrhotic Endothelial Progenitor Cells Enhance Liver Angiogenesis and Fibrosis and Aggravate Portal Hypertension in Bile Duct-Ligated Cirrhotic Rats
por: Tripathi, Dinesh Mani, et al.
Publicado: (2020)

Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis
por: Gao, Jin-Hang, et al.
Publicado: (2013)

Adrenal Dysfunction in Portal Hypertensive Rats with Acute Hemorrhage
por: Lee, Fa-Yauh, et al.
Publicado: (2014)

Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients
por: Wu, Pei-Shan, et al.
Publicado: (2021)

Dehydroepiandrosterone sulfate and dehydroepiandrosterone sulfate/cortisol ratio in cirrhotic patients with septic shock: another sign of hepatoadrenal syndrome?
por: Tsai, Ming-Hung, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tgv1dssiikchft28d8r99vefep